Roivant Sciences Ltd.
NASDAQ:ROIV
11.07 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1,969.914 | 5,678.514 | 6,535.706 | 6,670.81 | 1,408.231 | 1,434.093 | 1,681.824 | 1,531.405 |
| Short Term Investments
| 3,428.021 | -9.377 | 5.367 | 5.165 | 5.474 | -10.291 | 0 | 0 |
| Cash and Short Term Investments
| 5,397.935 | 5,683.923 | 6,541.073 | 6,675.975 | 1,413.705 | 1,439.357 | 1,681.824 | 1,531.405 |
| Net Receivables
| 22.684 | 82.813 | 63.188 | 54.624 | 39.914 | 39.914 | 32.735 | 29.454 |
| Inventory
| 0 | 33.997 | 35.251 | 5.24 | 4.905 | 4.225 | 2.761 | 0 |
| Other Current Assets
| 380.5 | 72.691 | 81.231 | 70.317 | 73.722 | 77.662 | 81.267 | 85.373 |
| Total Current Assets
| 5,801.119 | 6,001.499 | 6,731.828 | 6,806.733 | 1,551.627 | 1,561.158 | 1,798.587 | 1,646.232 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 56.651 | 63.153 | 65.95 | 68.755 | 73.106 | 87.901 | 92.337 | 91.931 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 136.009 | 137.842 | 150.415 | 140.621 | 145.037 | 144.881 | 146.105 |
| Goodwill and Intangible Assets
| 0 | 136.009 | 137.842 | 150.415 | 140.621 | 145.037 | 144.881 | 146.105 |
| Long Term Investments
| 319.523 | 272.356 | 247.753 | 239.927 | 250.393 | 306.534 | 314.608 | 282.101 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 28.735 | 23.431 | 39.109 | 46.849 | 49.796 | 36.016 | 39.191 | 36.591 |
| Total Non-Current Assets
| 404.909 | 494.949 | 490.654 | 505.946 | 513.916 | 575.488 | 591.017 | 556.728 |
| Total Assets
| 6,206.028 | 6,496.448 | 7,222.482 | 7,312.679 | 2,065.543 | 2,136.646 | 2,389.604 | 2,202.96 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 25.127 | 53.225 | 35.226 | 35.226 | 44.123 | 50.035 | 37.83 | 47.999 |
| Short Term Debt
| 9.519 | 21.893 | 56.183 | 59.901 | 55.754 | 55.754 | 54.503 | 49.587 |
| Tax Payables
| 1.358 | 23.442 | 10.469 | 25.223 | 1.358 | 1.244 | 0 | 0.813 |
| Deferred Revenue
| 3.411 | 2.66 | 4.168 | 4.695 | 5.798 | 10.569 | 12.444 | 7.796 |
| Other Current Liabilities
| 516.834 | 164.03 | 138.326 | 119.854 | 158.513 | 127.402 | 167.671 | 138.06 |
| Total Current Liabilities
| 556.249 | 215.045 | 266.758 | 244.899 | 265.546 | 245.004 | 272.448 | 244.255 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 43.19 | 477.856 | 450.396 | 438.075 | 436.881 | 436.881 | 432.565 | 430.049 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 26.547 | 29.339 | 32.802 | 45.123 | 37.483 | 120.622 | 77.004 | 101.518 |
| Total Non-Current Liabilities
| 69.737 | 386.117 | 507.195 | 483.198 | 474.364 | 557.503 | 509.569 | 531.567 |
| Total Liabilities
| 625.986 | 601.162 | 773.953 | 728.097 | 739.91 | 802.507 | 782.017 | 775.822 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| 395.58 | 671.469 | 576.172 | 727.287 | -4,368.897 | -4,064.57 | -3,772.754 | -3,739.137 |
| Accumulated Other Comprehensive Income/Loss
| -18.036 | -17.948 | -4.083 | -27.784 | -3.072 | -6.61 | -2.617 | -0.729 |
| Other Total Stockholders Equity
| 5,202.498 | 5,396.492 | 5,390.26 | 249.031 | 5,282.699 | 4,981.91 | 4,933.137 | 4,695.386 |
| Total Shareholders Equity
| 5,580.042 | 5,435.309 | 5,968.581 | 6,089.763 | 948.534 | 910.73 | 1,157.766 | 955.52 |
| Total Equity
| 6,007.129 | 5,895.286 | 6,448.529 | 6,584.582 | 1,325.633 | 1,334.139 | 1,607.587 | 1,427.138 |
| Total Liabilities & Shareholders Equity
| 6,206.028 | 6,496.448 | 7,222.482 | 7,312.679 | 2,065.543 | 2,136.646 | 2,389.604 | 2,202.96 |